Paeonol Ameliorates Abdominal Aortic Aneurysm Progression by the NF-κB Pathway
Paeonol Ameliorates Abdominal Aortic Aneurysm Progression by the NF-κB Pathway
复制标题
丹皮酚通过 NF-κB 途径改善腹主动脉瘤进展。
DOI:
10.1016/j.avsg.2021.06.003
复制
发表时间:
2021-12-18
影响因子:
1.5
通讯作者:
Li, Gang
中科院分区:
文献类型:
--
作者:
Chen, Shuxiao;Luo, Kun;Li, Gang
Objective: Abdominal aortic aneurysm (AAA) is a chronic inflammatory disease characterized by localized progressive dilatation. Currently, paeonol has been shown to possess anti-inflammatory and protective cardiovascular properties. Our study aimed to investigate the potential influences of paeonol on AAA progression.Methods: Experimental AAAs were created in C57BL/6J mice by intra-aortic infusion of porcine pancreatic elastase, and then intragastrically administered paeonol (20 mg/kg/day) for 14 days. The effects of paeonol on experimental AAA were measured by ultrasound imaging, histopathology, and western blot analyses.Results: Paeonol treatment limited the enlargement of the aneurysmal diameter and alleviated the depletion of elastic fibers and vascular smooth muscle cells (VSMCs). Furthermore, the infiltration of CD68+ macrophages and CD8+ lymphocytes was obviously attenuated after paeonol administration, along with mural neoangiogenesis. Western blot results showed that paeonol inhibited the expression of matrix metalloproteinase (MMP) and the NF-kappa B pathway activation.Conclusions: Paeonol might prevent experimental AAA progression by inhibiting the NF-kappa B pathway, which suggests that it is a potential drug for AAA.